Delta 9 Tetrahydrocannabinol for Nighttime Agitation in Severe Dementia

• $39.95
• 1 mg
• Link.springer.com

This scientific article investigates the use of delta-9-tetrahydrocannabinol (THC) in managing nighttime agitation among patients with severe dementia. Drawing upon a small-scale open-label pilot study involving six participants, researchers assessed how low doses of THC influenced both objective measures of movement via actigraphy and subjective caregiver reports through standardized scales.